Advertisement

Picture Berlin Partner Voices Uirá Souto Melo Lucid Genomics 650x100px
Person › Details

Ulrich Dauer (Probiodrug AG (Euronext Amsterdam: PBD))

Dauer, Ulrich (Probiodrug 201805– CEO before Omeicos + Activaero + 4SC + Tripos)

 

Organisations Organisation Probiodrug AG (Euronext Amsterdam: PBD)
  Today Vivoryon Therapeutics AG (Euronext Amsterdam: VVY)
  Group Vivoryon (Group)
  Former/major organisation Omeicos Therapeutics GmbH
  Group Omeicos (Group)
Products Product PQ912 (Probiodrug)
  Product 2 Alzheimer drug
     

   
Record changed: 2023-09-21

Advertisement

Picture Berlin Partner Join Cluster HealthCapital Berlin Brandenburg 650x200px


More documents for Ulrich Dauer


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x300px




» top